Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy

Purpose: Proton vertebral body sparing craniospinal irradiation (CSI) treats the thecal sac while avoiding the anterior vertebral bodies in an effort to reduce myelosuppression and growth inhibition. However, robust treatment planning needs to compensate for proton range uncertainty, which contribut...

Full description

Bibliographic Details
Main Authors: Chih-Wei Chang, PhD, Matt Goette, PhD, Nadja Kadom, MD, Yinan Wang, MD, Jacob Wynne, MD, Tonghe Wang, PhD, Tian Liu, PhD, Natia Esiashvili, MD, Jun Zhou, PhD, Bree R. Eaton, MD, Xiaofeng Yang, PhD
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109423000969
_version_ 1797814378192437248
author Chih-Wei Chang, PhD
Matt Goette, PhD
Nadja Kadom, MD
Yinan Wang, MD
Jacob Wynne, MD
Tonghe Wang, PhD
Tian Liu, PhD
Natia Esiashvili, MD
Jun Zhou, PhD
Bree R. Eaton, MD
Xiaofeng Yang, PhD
author_facet Chih-Wei Chang, PhD
Matt Goette, PhD
Nadja Kadom, MD
Yinan Wang, MD
Jacob Wynne, MD
Tonghe Wang, PhD
Tian Liu, PhD
Natia Esiashvili, MD
Jun Zhou, PhD
Bree R. Eaton, MD
Xiaofeng Yang, PhD
author_sort Chih-Wei Chang, PhD
collection DOAJ
description Purpose: Proton vertebral body sparing craniospinal irradiation (CSI) treats the thecal sac while avoiding the anterior vertebral bodies in an effort to reduce myelosuppression and growth inhibition. However, robust treatment planning needs to compensate for proton range uncertainty, which contributes unwanted doses within the vertebral bodies. This work aimed to develop an early in vivo radiation damage quantification method using longitudinal magnetic resonance (MR) scans to quantify the dose effect during fractionated CSI. Methods and Materials: Ten pediatric patients were enrolled in a prospective clinical trial of proton vertebral body sparing CSI, in which they received 23.4 to 36 Gy. Monte Carlo robust planning was used, with spinal clinical target volumes defined as the thecal sac and neural foramina. T1/T2-weighted MR scans were acquired before, during, and after treatments to detect a transition from hematopoietic to less metabolically active fatty marrow. MR signal intensity histograms at each time point were analyzed and fitted by multi-Gaussian models to quantify radiation damage. Results: Fatty marrow filtration was observed in MR images as early as the fifth fraction of treatment. Maximum radiation-induced marrow damage occurred 40 to 50 days from the treatment start, followed by marrow regeneration. The mean damage ratios were 0.23, 0.41, 0.59, and 0.54, corresponding to 10, 20, 40, and 60 days from the treatment start. Conclusions: We demonstrated a noninvasive method for identifying early vertebral marrow damage based on radiation-induced fatty marrow replacement. The proposed method can be potentially used to quantify the quality of CSI vertebral sparing and preserve metabolically active hematopoietic bone marrow.
first_indexed 2024-03-13T08:06:49Z
format Article
id doaj.art-f05a0355a49340f7a372e84a92ee981c
institution Directory Open Access Journal
issn 2452-1094
language English
last_indexed 2024-03-13T08:06:49Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Advances in Radiation Oncology
spelling doaj.art-f05a0355a49340f7a372e84a92ee981c2023-06-01T04:36:42ZengElsevierAdvances in Radiation Oncology2452-10942023-09-0185101267Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton TherapyChih-Wei Chang, PhD0Matt Goette, PhD1Nadja Kadom, MD2Yinan Wang, MD3Jacob Wynne, MD4Tonghe Wang, PhD5Tian Liu, PhD6Natia Esiashvili, MD7Jun Zhou, PhD8Bree R. Eaton, MD9Xiaofeng Yang, PhD10Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GeorgiaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GeorgiaDepartment of Radiology and Imaging Sciences, Emory University and Children's Healthcare of Atlanta, Atlanta, GeorgiaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GeorgiaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GeorgiaDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New YorkDepartment of Radiation Oncology, Mount Sinai Medical Center, New York, New YorkDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GeorgiaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GeorgiaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia; Corresponding authors: Bree R. Eaton, MD; and Xiaofeng Yang, PhDDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia; Corresponding authors: Bree R. Eaton, MD; and Xiaofeng Yang, PhDPurpose: Proton vertebral body sparing craniospinal irradiation (CSI) treats the thecal sac while avoiding the anterior vertebral bodies in an effort to reduce myelosuppression and growth inhibition. However, robust treatment planning needs to compensate for proton range uncertainty, which contributes unwanted doses within the vertebral bodies. This work aimed to develop an early in vivo radiation damage quantification method using longitudinal magnetic resonance (MR) scans to quantify the dose effect during fractionated CSI. Methods and Materials: Ten pediatric patients were enrolled in a prospective clinical trial of proton vertebral body sparing CSI, in which they received 23.4 to 36 Gy. Monte Carlo robust planning was used, with spinal clinical target volumes defined as the thecal sac and neural foramina. T1/T2-weighted MR scans were acquired before, during, and after treatments to detect a transition from hematopoietic to less metabolically active fatty marrow. MR signal intensity histograms at each time point were analyzed and fitted by multi-Gaussian models to quantify radiation damage. Results: Fatty marrow filtration was observed in MR images as early as the fifth fraction of treatment. Maximum radiation-induced marrow damage occurred 40 to 50 days from the treatment start, followed by marrow regeneration. The mean damage ratios were 0.23, 0.41, 0.59, and 0.54, corresponding to 10, 20, 40, and 60 days from the treatment start. Conclusions: We demonstrated a noninvasive method for identifying early vertebral marrow damage based on radiation-induced fatty marrow replacement. The proposed method can be potentially used to quantify the quality of CSI vertebral sparing and preserve metabolically active hematopoietic bone marrow.http://www.sciencedirect.com/science/article/pii/S2452109423000969
spellingShingle Chih-Wei Chang, PhD
Matt Goette, PhD
Nadja Kadom, MD
Yinan Wang, MD
Jacob Wynne, MD
Tonghe Wang, PhD
Tian Liu, PhD
Natia Esiashvili, MD
Jun Zhou, PhD
Bree R. Eaton, MD
Xiaofeng Yang, PhD
Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy
Advances in Radiation Oncology
title Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy
title_full Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy
title_fullStr Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy
title_full_unstemmed Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy
title_short Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy
title_sort early in vivo radiation damage quantification for pediatric craniospinal irradiation using longitudinal mri for intensity modulated proton therapy
url http://www.sciencedirect.com/science/article/pii/S2452109423000969
work_keys_str_mv AT chihweichangphd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT mattgoettephd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT nadjakadommd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT yinanwangmd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT jacobwynnemd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT tonghewangphd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT tianliuphd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT natiaesiashvilimd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT junzhouphd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT breereatonmd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy
AT xiaofengyangphd earlyinvivoradiationdamagequantificationforpediatriccraniospinalirradiationusinglongitudinalmriforintensitymodulatedprotontherapy